Analysis Group Health Care Researchers' Gout Study Published in American Journal of Therapeutics

January 31, 2013

A study on therapy patterns for patients with chronic gout conducted by Analysis Group health care researchers has been published in the American Journal of Therapeutics (November 2012). The study, "Comorbidity Burden, Healthcare Resource Utilization, and Costs in Chronic Gout Patients Refractory to Conventional Urate-Lowering Therapy," was conducted by a team including Managing Principal Eric Wu, Senior Economist Annie Guérin, and Economist Dominick Latremouille-Viau.

The study examined health care resource use and costs in patients with refractory gout in comparison with a control group. The research found that gout patients incurred $10,222 more in annual health care costs compared to the control group, with 40 percent of their total annual medical costs going to gout-related care. According to Dr. Wu, "Gout patients had a significantly higher incidence of emergency room and outpatient visits, hospitalizations, and other medical services. Patients with refractory gout have a significant economic burden compared with a gout-free population."

Read the abstract